These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37159522)

  • 1. Effect of Neonatal Abstinence Syndrome Treatment Status and Maternal Depressive Symptomatology on Maternal Reports of Infant Behaviors.
    Heller NA; Logan BA; Shrestha H; Morrison DG; Hayes MJ
    J Pediatr Psychol; 2023 Jul; 48(6):583-592. PubMed ID: 37159522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal abstinence syndrome: Neurobehavior at 6 weeks of age in infants with or without pharmacological treatment for withdrawal.
    Heller NA; Logan BA; Morrison DG; Paul JA; Brown MS; Hayes MJ
    Dev Psychobiol; 2017 Jul; 59(5):574-582. PubMed ID: 28561904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates.
    Jansson LM; Dipietro JA; Elko A; Velez M
    J Matern Fetal Neonatal Med; 2007 Sep; 20(9):677-85. PubMed ID: 17701668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
    Velez ML; Jordan C; Jansson LM
    Neurotoxicol Teratol; 2021; 88():107032. PubMed ID: 34600100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Could prenatal food insecurity influence neonatal abstinence syndrome severity?
    Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM
    Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Abstinence Syndrome Severity Index Predicts 18-Month Neurodevelopmental Outcome in Neonates Randomized to Morphine or Methadone.
    Flannery T; Davis JM; Czynski AJ; Dansereau LM; Oliveira EL; Camardo SA; Lester BM
    J Pediatr; 2020 Dec; 227():101-107.e1. PubMed ID: 32805259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure.
    Faherty LJ; Matone M; Passarella M; Lorch S
    Matern Child Health J; 2018 Jun; 22(6):841-848. PubMed ID: 29417369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
    Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
    Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal Substance Use and Neonatal Abstinence Syndrome: A Descriptive Study.
    McQueen KA; Murphy-Oikonen J; Desaulniers L
    Matern Child Health J; 2015 Aug; 19(8):1756-65. PubMed ID: 25656717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal methadone exposure and neonatal neurobehavioral functioning.
    Velez ML; Jansson LM; Schroeder J; Williams E
    Pediatr Res; 2009 Dec; 66(6):704-9. PubMed ID: 19690513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in Infant CYP2B6 Genotype Associated with the Need for Pharmacological Treatment for Neonatal Abstinence Syndrome in Infants of Methadone-Maintained Opioid-Dependent Mothers.
    Mactier H; McLaughlin P; Gillis C; Osselton MD
    Am J Perinatol; 2017 Jul; 34(9):918-921. PubMed ID: 28320034
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants.
    McQueen KA; Murphy-Oikonen J; Gerlach K; Montelpare W
    Adv Neonatal Care; 2011 Aug; 11(4):282-90. PubMed ID: 22123351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
    Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
    JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal buprenorphine exposure and neonatal neurobehavioral functioning.
    Velez ML; McConnell K; Spencer N; Montoya L; Tuten M; Jansson LM
    Early Hum Dev; 2018 Feb; 117():7-14. PubMed ID: 29223912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure to methadone or buprenorphine: Early childhood developmental outcomes.
    Kaltenbach K; O'Grady KE; Heil SH; Salisbury AL; Coyle MG; Fischer G; Martin PR; Stine S; Jones HE
    Drug Alcohol Depend; 2018 Apr; 185():40-49. PubMed ID: 29413437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term mortality in mothers of infants with neonatal abstinence syndrome: A population-based parallel-cohort study in England and Ontario, Canada.
    Guttmann A; Blackburn R; Amartey A; Zhou L; Wijlaars L; Saunders N; Harron K; Chiu M; Gilbert R
    PLoS Med; 2019 Nov; 16(11):e1002974. PubMed ID: 31770382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT (NASCENT) program: protocol for a stepped wedge cluster randomized trial of a hospital-level Neonatal Abstinence Syndrome rooming-in intervention.
    Wine O; McNeil D; Kromm SK; Foss K; Caine V; Clarke D; Day N; Johnson DW; Rittenbach K; Wood S; Hicks M
    BMC Health Serv Res; 2023 May; 23(1):448. PubMed ID: 37149626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach.
    Velez ML; Jordan CJ; Jansson LM
    Neurotoxicol Teratol; 2021; 88():107020. PubMed ID: 34419619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breastfeeding promotion for management of neonatal abstinence syndrome.
    Pritham UA
    J Obstet Gynecol Neonatal Nurs; 2013; 42(5):517-26. PubMed ID: 24020477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-Year Postpartum Mental Health Outcomes of Mothers of Infants with Neonatal Abstinence Syndrome.
    Corr TE; Schaefer EW; Hollenbeak CS; Leslie DL
    Matern Child Health J; 2020 Mar; 24(3):283-290. PubMed ID: 31925632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.